JWCA
NMTR

J.W. Cole Advisors’s 9 Meters Biopharma NMTR Stock Holding History

J.W. Cole Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,250
Closed -$14K – 776
2022
Q3 		$14K Buy
3,250
+500
+18% +$2.48K ﹤0.01% 724
2022
Q2 		$14K Hold
2,750
– – ﹤0.01% 732
2022
Q1 		$33K Buy
2,750
+500
+22% +$6.83K ﹤0.01% 800
2021
Q4 		$44K Buy
2,250
+750
+50% +$16.8K ﹤0.01% 826
2021
Q3 		$39K Buy
1,500
+125
+9% +$2.95K ﹤0.01% 473
2021
Q2 		$30K Hold
1,375
– – ﹤0.01% 732
2021
Q1 		$32K Buy
1,375
+125
+10% +$3.84K ﹤0.01% 663
2020
Q4 		$21K Buy
1,250
+500
+67% +$8.34K ﹤0.01% 628
2020
Q3 		$12K Buy
+750
New +$9.09K ﹤0.01% 761

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

J.W. Cole Advisors's NMTR Position: Q4 2022 in Review

J.W. Cole Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 3,250 shares — an estimated $14K sold.

J.W. Cole Advisors first reported a position in NMTR in Q3 2020 and held it in 9 quarters. The position peaked at $44K in Q4 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • J.W. Cole Advisors reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • J.W. Cole Advisors sold 3,250 9 Meters Biopharma shares in Q4 2022, an estimated $14K.
  • J.W. Cole Advisors first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 9 quarters.
  • J.W. Cole Advisors's 9 Meters Biopharma position peaked at $44K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on J.W. Cole Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.